| Predicted Trait | |
| Reported Trait | Ischemic stroke |
| Mapped Trait(s) | Ischemic stroke (HP_0002140) |
| Score Construction | |
| PGS Name | IS_PRSCS_SBayesRC_AFR |
| Development Method | |
| Name | SBayesRC |
| Parameters | NR |
| Variants | |
| Original Genome Build | GRCh38 |
| Number of Variants | 6,064,174 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000839 |
| Citation (link to publication) | Armstrong ND et al. Front Bioinform (2026) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | African: 100% 20,924 individuals (100%) |
| Score Development/Training | African: 100% 6,342 individuals (100%) |
| PGS Evaluation | African: 100% 2 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST90104550 Europe PMC: 36180795 |
20,924 individuals | African American or Afro-Caribbean | 10 cohorts
|
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| — | [ ,
39.1 % Male samples |
African American or Afro-Caribbean | REGARDS | — | Mean = 63.6 years Sd = 9.2 years |
— | — | ischemic stroke - ischemic stroke events in REGARDS were identified through biannual surveillance and adjudicated via medical record review. For participants aligned to Medicare claims, additional ischemic stroke events were identified from inpatient claims using ICD-9 codes 433.x1 or 434.x1 or ICD-10 codes I63.xx in the primary diagnosis position. Hospitalizations occurring within one day of each other were merged into a single episode of care. Participants with self-reported stroke at baseline were excluded. |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM038127 | PSS013828| African Ancestry| 29,594 individuals |
PGP000839 | Armstrong ND et al. Front Bioinform (2026) |
Reported Trait: ischemic stroke | OR: 0.993 [0.943, 1.046] | AUROC: 0.66677 | — | age, sex, PC 1-10 | — |
| PPM038133 | PSS013830| African Ancestry| 6,908 individuals |
PGP000839 | Armstrong ND et al. Front Bioinform (2026) |
Reported Trait: Stroke | OR: 1.009 [0.891, 1.143] | AUROC: 0.6416 [0.6135, 0.6696] | — | age, sex, PC 1-10, trial antihypertensive group | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS013828 | — | — | [ ,
46.1 % Male samples |
Mean = 63.3 years Sd = 8.1 years |
African American or Afro-Caribbean | — | AllofUs | To harmonize phenotype definitions with REGARDS, analyses in All of Us were restricted to participants aged ≥45 years. IS cases were defined as individuals with an inpatient encounter associated with ICD-9 codes 433.x1 or 434.x1, or ICD-10 codes I63.xx. Stroke codes identified only in non-inpatient encounters, SNOMED stroke codes, and hemorrhagic stroke codes (ICD-9 430.x, 431.x; ICD-10 I60.x, I61.x) were excluded from both case and control sets. |
| PSS013830 | — | — | [ ,
44.6 % Male samples |
Mean = 66.2 years Sd = 7.8 years |
African American or Afro-Caribbean | — | GenHAT | Incident stroke in GenHAT was defined as a persistent neurological deficit resulting from arterial occlusion or rupture, lasting >24 hours (unless fatal), or with CT/MRI evidence consistent with acute stroke, excluding stroke due to trauma, infection, tumor, or other non-ischemic causes. Events occurring perioperatively were included. In the primary ALLHAT study, the type of stroke (specifically differentiating between ischemic and hemorrhagic) was not systematically classified or reported as part of the trial's pre-specific secondary outcomes; therefore, stroke was analyzed as an all-stroke phenotype in this cohort. |